GD
52
-5
CAG
31
-3
DTE
50
-6
MAS
60
-3
BF.B
39
-4
NOC
37
-7
HSY
47
16
ABT
54
-2
TRV
53
-2
ADI
56
2
RF
58
-3
KO
38
2
AIV
51
-3
XRAY
20
-2
LRCX
50
2
CVS
41
-2
XEL
50
-7
GOOGL
58
2
APD
54
-3
FLR
55
-4
GD
52
-5
CAG
31
-3
DTE
50
-6
MAS
60
-3
BF.B
39
-4
NOC
37
-7
HSY
47
16
ABT
54
-2
TRV
53
-2
ADI
56
2
RF
58
-3
KO
38
2
AIV
51
-3
XRAY
20
-2
LRCX
50
2
CVS
41
-2
XEL
50
-7
GOOGL
58
2
APD
54
-3
FLR
55
-4
Financhill
Back

Corbus Pharmaceuticals Holdings 10K Form

Sell
20

CRBP
Corbus Pharmaceuticals Holdings

Last Price:
16.78
Seasonality Move:
14.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRBP News And Ratings

See the #1 stock for the next 7 days that we like better than CRBP

CRBP Financial Statistics

Sales & Book Value

Annual Sales: $881.71K
Cash Flow: $-8.94M
Price / Cash Flow: 0
Annual Sales: $10.92
Price / Book: 1.55

Profitability

EPS (TTM): -5.79000
Net Income (TTM): $-34.97M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Corbus Pharmaceuticals Holdings Earnings Forecast

Key Corbus Pharmaceuticals Holdings Financial Ratios

  • The Selling, General & Administrative Expenses for CRBP have been equal to 2,316.57% of Gross Profit Margin.
  • The Interest Expense is -0.95% of Operating Income.
  • Per Share Earnings over the last 11 years have been positive in 2 years.

Corbus Pharmaceuticals Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CRBP
CUSIP: 21833P
Website: corbuspharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CRBP Technical Analysis vs Fundamental Analysis

Sell
20
Corbus Pharmaceuticals Holdings (CRBP) is a Sell

Is Corbus Pharmaceuticals Holdings a Buy or a Sell?